Dean, College of Engineering, University of Michigan
President of Stratos Product Development
Partner, Emerging Companies and Life Sciences, Cooley LLP
Scientist and Managing Dir., Microsoft Research New England
Dean, Harvard School of Engineering and Applied Sciences
Chairman, CEO, Acucela
Scientist and Managing Dir., Microsoft Research New England
President and CEO, Onyx Pharmaceuticals
|
Greg Pass is bringing more technology “street cred” to the team that is establishing the applied science and engineering campus on Roosevelt Island in New York. The former chief technology officer of Twitter on Wednesday was named the founding entrepreneurial officer... Read more »
San Diego Xconomist Evan Snyder has been called a “stem cell revolutionary” and is regarded as a father in the field of stem cell research. When we talked in his office at San Diego’s Sanford-Burnham Medical Research Institute, he told me he... Read more »
On the iPhone, the first page of the home screen—the one you see when you wake up the device—has room for only 20 apps, counting those in the dock. The iPad home screen holds 26. For me, that means the home... Read more »
On June 1, cancer scientists and drugmakers will flock to Chicago for the annual meeting of the American Society of Clinical Oncology (ASCO). The gathering is so prominent that many pharmaceutical companies hold off on releasing data from their clinical trials... Read more »
A team developing analytic software that scores patients for the risk they pose to being readmitted within 30 days after being discharged from a hospital is the winner of the inaugural Janssen Connected Care Challenge. The prize is sponsored by Janssen, a unit... Read more »
Taking another crack at building a company, Duy Huynh thinks MakeDirect, his latest New York-based startup, can scale up quickly by breaking old traditions in manufacturing. The company’s e-commerce site lets consumers buy furniture direct from the factory, but moreover, Huynh is... Read more »
On April 2, shares of New York-based Keryx Pharmaceuticals (NASDAQ: KERX) fell a stomach-churning 65 percent to $1.74 after the company announced that a late-stage trial of its colon cancer drug failed. But CEO Ron Bentsur was unfazed. In fact, he was... Read more »
Founder and Managing Director, New Leaf Venture Partners
Professor of Molecular Biology, Rockefeller University
Executive Director, NY Tech Meetup and Advisor, Flybridge Capital
Co-Founder, Meetup.com
Co-Founder, Exelixis Inc., and Anadys Pharmaceuticals Inc.
Managing Partner, Rho Capital Partners and Rho Ventures
Chairman, EDventure Holdings
President, Rockefeller University
Founder and Managing Partner, IA Ventures
Product Manager, Foursquare
San Francisco · 6/7/12
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
